Table 1.
Distribution of the participating women according to HPV infection subtype across the study groups. V1: vaccinated women with HPV DNA-positive and mRNA-negative results, NV1: non-vaccinated women with HPV DNA-positive and mRNA-negative results, V2: vaccinated women with HPV DNA- and mRNA-positive results, NV2: non-vaccinated women with HPV DNA- and mRNA-positive results.
| Group / HPV subtype | HPV16 | HPV18 | HPV31 | HPV33 | HPV45 | Total |
|---|---|---|---|---|---|---|
| V1 | 24 | 25 | 28 | 18 | 4 | 99 |
| NV1 | 28 | 25 | 20 | 17 | 3 | 93 |
| V2 | 12 | 13 | 15 | 11 | 2 | 53 |
| NV2 | 13 | 20 | 16 | 14 | 1 | 64 |
| Total | 77 | 83 | 79 | 60 | 10 | 309 |